2018-08-15T09:48:47-05:00 2017-12-31 521511275 RAFFA PC 1899 L STREET NW SUITE 850 WASHINGTON DC 20036 990 2017-01-01 510178702 RADIATION ONCOLOGY INSTITUTE RADI 7035021550 251 18TH ST SOUTH 8TH FLOOR ARLINGTON VA 22202 LAURA I THEVENOT EX-OFFICIO, EXECUTIVE DIRECTOR 7035021550 2018-08-15 1 FRANK H SMITH P00639053 2028225000 2018-08-14 2017 2022-09-23 18:48:47Z LAURA I THEVENOT 251 18TH ST SOUTH 8TH FLOOR ARLINGTON VA 22202 4037259 0 X WWW.ROINSTITUTE.ORG X 1978 IL TO ENHANCE AND PROMOTE THE CRITICAL ROLE OF RADIATION THERAPY IN THE TREATMENT OF CANCER. 13 13 0 52 0 0 379906 451618 0 0 456274 710540 0 0 836180 1162158 149727 215687 0 0 159284 201950 0 0 153621 257186 239626 566197 657263 269983 504895 11866502 13299739 38117 12606 11828385 13287133 X THE RADIATION ONCOLOGY INSTITUTE (ROI) WILL ENHANCE AND PROMOTE THE CRITICAL ROLE OF RADIATION THERAPY IN THE TREATMENT OF CANCER BY SUPPORTING RESEARCH AND EDUCATION ABOUT THE LIVE-SAVING AND QUALITY-OF-LIFE BENEFITS OF RADIATION THERAPY. 0 0 129094 125000 SAFETY AND QUALITY - THE BIG DATA PROJECT PROVIDES NEW OPPORTUNITIES TO IMPROVE QUALITY ASSURANCE AND QUALITY IMPROVEMENT EFFORTS BY MAKING IT POSSIBLE TO TARGET AND BETTER FOCUS RESOURCES WHERE THEY ARE MOST NEEDED. CURRENT QUALITY ASSURANCE METHODS OFTEN TAKE A UNIFORM APPROACH, TREATING EVERY PATIENT CASE IN A BROAD CATEGORY WITH THE SAME PROCESS AND INTENSITY OF EXAMINATION. THIS PROGRAM SEEKS TO LEVERAGE BIG DATA TO OPTIMIZE QUALITY ASSURANCE AND PATIENT CARE IMPROVEMENTS INITIATIVES. 102402 73672 TOXICITY MANAGEMENT PROJECT - DEALS WITH THE MANAGEMENT AND ON-GOING FOLLOW-UP OF ADVERSE EFFECTS RELATED TO RADIATION THERAPY. THE RADONC TOOLBOX APP AND WEBSITE WILL IMPROVE COMMUNICATION AND KNOWLEDGE AMONG NON-RADIATION THERAPY HEALTH CARE PROVIDERS IN ORDER TO IMPROVE PATIENT OUTCOMES AND QUALITY OF LIFE METRICS. A RESEARCH PROJECT USING ACTIVITY TRACKERS IS TESTING WHETHER A SIMPLE WALKING PROGRAM COULD LESSEN TREATMENT-RELATED TOXICITIES AND IMPROVE PATIENT QUALITY OF LIFE. 17145 6835 VALUE OF RADIATION THERAPY - PROJECT EXAMINES THE COMPARATIVE VALUE OF RADIOTHERAPY IN ORDER TO GENERATE THE EVIDENCE NEEDED TO IMPROVE CANCER OUTCOMES WHILE SLOWING THE GROWTH OF HEALTHCARE SPENDING. 28914 10180 OTHER PROGRAMS 28914 10180 277555 1 1 0 0 0 0 0 0 0 1 0 0 0 0 0 1 1 1 0 0 0 0 0 0 0 0 0 1 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 1 0 1 1 0 1 0 0 0 0 0 0 0 0 0 0 0 X 13 13 0 1 0 0 0 0 0 1 1 0 0 1 1 1 1 1 1 0 0 0 IL VA X PATRICIA B LAWLOR 7035021550 251 18TH ST SOUTH 8TH FLOOR ARLINGTON VA 22202 DEBORAH A KUBAN PRESIDENT 1.00 X X 0 0 0 COLLEEN A F LAWTON VICE PRESIDENT 1.00 X X 0 0 0 TIMOTHY E GUERTIN PUBLIC TRUSTEE AND TREASURER 1.00 X X 0 0 0 THEODORE S LAWRENCE IMMEDIATE PAST PRESIDENT 1.00 X X 0 0 0 THEODORE L DEWEESE ASTRO REPRESENTATION - UNTIL 09/2017 1.00 2.00 X 0 0 0 JAMES P HOEY PUBLIC TRUSTEE 1.00 X 0 0 0 JOSEPH K JACHINOWSKI PUBLIC TRUSTEE 1.00 X 0 0 0 BRUCE D MINSKY ASTRO REPRESENTATION - UNTIL 09/2017 1.00 2.00 X 0 0 0 CHRISTOPHER M ROSE TRUSTEE 1.00 X 0 0 0 TIM WILLIAMS TRUSTEE 1.00 X 0 0 0 J FRANK WILSON TRUSTEE 1.00 X 0 0 0 DAVID C BEYER ASTRO REPRESENTATION 1.00 2.00 X 0 0 0 DANIEL LOW ASTRO REPRESENTATION 1.00 2.00 X 0 0 0 LAURA I THEVENOT EX-OFFICIO, EXECUTIVE DIRECTOR 4.00 36.00 X 0 705996 92975 0 705996 92975 0 0 1 0 0 198633 252985 451618 220162 220162 3365479 2875101 490378 490378 490378 1162158 0 0 710540 215687 215687 201950 37744 97054 67152 360 360 14515 14515 38243 38243 13279 5862 7417 29263 142 8765 20356 26789 537 18474 7778 166 166 4279 4279 OVERHEAD ALLOCATION 92146 17223 44283 30640 DUES AND PUBLICATIONS 10586 0 474 10112 BAD DEBT EXPENSE 10000 0 0 10000 657263 277555 226087 153621 279862 182657 226295 280688 665183 303430 5380 26650 6856 4953 10666171 12484606 16755 16755 11866502 13299739 14690 12606 23427 0 38117 12606 X 2097704 2687213 82800 753406 9647881 9846514 11828385 13287133 11866502 13299739 504895 953853 0 X 0 1 X 1 0 X X 1 AMERICAN SOCIETY FOR RADIATION ONCOLOGY 420943164 10 0 10000 0 1 10000 0 1 0 1 1 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 PART IV, SECTION A, LINE 3B: ROI IS THE SUPPORTING ORGANIZATION FOR THE AMERICAN SOCIETY FOR RADIATION ONCOLOGY (ASTRO), A 501(C)(6) ORGANIZATION. ROI PERFORMED THE 509(A)(2) TEST FOR ASTRO AND FOUND THAT ASTRO'S SUPPORT PERCENTAGE EXCEEDS THE 33% MINIMUM OF PUBLIC SUPPORT THAT WOULD BE A REQUIREMENT IF ASTRO WERE DESCRIBED AS SUCH AN ENTITY. ACCORDINGLY, ROI IS ELIGIBLE TO SUPPORT ASTRO. RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 9169439 198633 1281972 192224 10457820 9117677 158021 414950 521209 9169439 9431266 272097 -172985 412701 9117677 9041538 361072 441358 412702 9431266 8335418 521273 1201604 976994 9081301 0.94150 0.05850 0 0 0 X 2100687 953853 22919 976772 1123915 38243 38243 1162158 641939 22919 22919 619020 38243 38243 657263 PART V, LINE 4: CURRENTLY, THE ENDOWMENT FUND IS A PERMANENTLY RESTRICTED FUND WHICH IS NOT AVAILABLE FOR USE. PART X, LINE 2: ROI PERFORMED AN EVALUATION OF UNCERTAINTY IN INCOME TAXES FOR THE YEAR ENDED DECEMBER 31, 2017, AND DETERMINED THAT THERE ARE NO MATTERS THAT WOULD REQUIRE RECOGNITION IN THE FINANCIAL STATEMENTS OR THAT MAY HAVE ANY EFFECT ON ITS TAX-EXEMPT STATUS. 1 JOHN HOPKINS UNIVERSITY 3910 KESWICK ROAD N4327-B BALTIMORE MD 21211 520595110 501(C)(3) 130500 RESEARCH GRANT MD ANDERSON CANCER CENTER 1515 HOLCOMBE BOULEVARD HOUSTON TX 77230 746001118 501(C)(3) 49990 RESEARCH GRANT ALBERT EINSTEIN COLLEGE OF MEDICINE 1300 MORRIS PARK AVENUE BRONX NY 10461 472209056 501(C)(3) 23682 RESEARCH GRANT AMERICAN SOCIETY FOR RADIATION ONCOLOGY 251 18TH STREET SOUTH 8TH FLOOR ARLINGTON VA 22202 420943164 501(C)(6) 10000 GENERAL SUPPORT 3 1 PART I, LINE 2: AS PER A SIGNED AGREEMENT LETTER, ROI REQUIRES ANY DEVIATION FROM THE FUNDED GRANT PROPOSAL TO BE SUBMITTED IMMEDIATELY IN WRITING TO ROI. IN ADDITION, AN INTERIM PROGRESS REPORT AND A FINAL REPORT ARE COLLECTED WHICH SUMMARIZE PROGRESS MADE AND EXPENDITURES. 0 0 0 0 0 0 0 0 0 LAURA I THEVENOT EX-OFFICIO, EXECUTIVE DIRECTOR 0 477364 0 91006 0 137626 0 56000 0 36975 0 798971 0 0 PART I, LINE 3 ROI DOES NOT DIRECTLY HIRE OR COMPENSATE EMPLOYEES. ALL EMPLOYEES ARE EMPLOYEES OF THE AMERICAN SOCIETY FOR RADIATION ONCOLOGY (ASTRO), A RELATED ORGANIZATION EXEMPT UNDER SECTION 501(C)(6). AN INDEPENDENT CONSULTANT PERFORMED A MARKET SURVEY TO DEVELOP SALARY STRUCTURE AND RANGES. ASTRO'S PRACTICE IS TO COMPLETE A MARKET SURVEY EVERY THREE YEARS; THIS WAS LAST COMPLETED FOR THE EX-OFFICIO, EXECUTIVE DIRECTOR IN 2016. THE EX-OFFICIO, EXECUTIVE DIRECTOR'S COMPENSATION IS DETERMINED BY A SUBCOMMITTEE OF THE BOARD USING COMPARABLE SALARIES OF SIMILAR EXECUTIVE DIRECTOR POSITIONS OF NONPROFIT MEDICAL ORGANIZATIONS. THIS REVIEW WAS DISCUSSED WITH THE BOARD OF DIRECTORS AND THE FINAL DETERMINATION WAS MADE BY THE EXECUTIVE COMMITTEE. FORM 990, PART VI, SECTION A, LINE 3 ALL MANAGEMENT FUNCTIONS OF ROI ARE CONTROLLED BY THE AMERICAN SOCIETY FOR RADIATION ONCOLOGY (ASTRO), A RELATED ORGANIZATION EXEMPT UNDER SECTION 501(C)(6). FORM 990, PART VI, SECTION B, LINE 11B THE FEDERAL FORM 990 IS PREPARED BY OUR EXTERNAL TAX ACCOUNTANTS. THE DRAFT IS PROVIDED TO OUR FINANCE STAFF FOR REVIEW BEFORE BEING SUBMITTED TO THE VP FINANCE & ADMINISTRATION, CEO, AND TREASURER OF ASTRO FOR THEIR REVIEW AND APPROVAL. THE REVISED DRAFT IS THEN PROVIDED TO THE FULL BOARD OF DIRECTORS PRIOR TO FILING WITH THE INTERNAL REVENUE SERVICE. FORM 990, PART VI, SECTION B, LINE 12C ROI'S OFFICERS, DIRECTORS, KEY EMPLOYEES, AND VOLUNTEERS ARE REQUIRED TO FILL OUT DISCLOSURE FORMS ON AN ANNUAL BASIS AND TO UPDATE THEIR DISCLOSURE FORMS UPON ANY MATERIAL CHANGE IN THE INTERIM. THESE DISCLOSURE FORMS ARE REVIEWED IN ORDER TO IDENTIFY AND ADDRESS ANY POTENTIAL CONFLICTS OF THESE INDIVIDUALS. FORM 990, PART VI, SECTION C, LINE 19 THE SUMMARY FINANCIAL STATEMENTS ARE AVAILABLE UPON REQUEST. GOVERNING DOCUMENTS AND CONFLICT OF INTEREST POLICY ARE AVAILABLE ON OUR WEBSITE. AMERICAN SOCIETY FOR RADIATION ONCOLOGY 251 18TH STREET SOUTH 8TH FLOOR ARLINGTON VA 22202 420943164 MEMBERSHIP SOCIETY IL 501(C)(6) N/A N/A 0 0 1 1 0 0 0 0 0 0 0 0 0 0 1 1 1 1 0 0 AMERICAN SOCIETY FOR RADIATION ONCOLOGY C 198633 ACTUAL AMERICAN SOCIETY FOR RADIATION ONCOLOGY N 92145 FMV AMERICAN SOCIETY FOR RADIATION ONCOLOGY O 201950 FMV